Abstract:[Objective] To systematically evaluate the safety of unilateral biportal endoscopic (UBE) lumbar interbody fusion versus con- ventional lumbar interbaody fusion surgery. [Methods] The Cochrane Library, PubMed, Embase, Web of Science, Clinical Trals.gov, CBM, CNKI, VIP and Wanfang Database were searched to collect all comparative studies on UBE and conventional lumbar interbody fusion sur- gery from the establishment of the database to April 13, 2022, and then RevMan5.3 software was used for meta-analysis, additionally de- scriptive qualitative analysis was performed for data that could not be combined. [Results] A total of 9 articles were enrolled into this study, all of which were retrospective cohort studies, including 7 high-quality articles and 2 medium-quality articles. A total of 796 patients were involved, including 365 in the UBE group and 431 in the conventional group. As results of meta-analysis, there were no significant differenc- es in terms of total complication rates (OR=0.94, 95%CI 0.57~1.53, P=0.800), the incidence of epidural hematoma (OR=1.16, 95%CI 0.38~ 3.52, P=0.800), incidence of dural tear (OR=1.80, 95%CI 0.76~4.30, P=0.180), and incidence of infection (OR=0.35, 95%CI 0.09~1.30, P= 0.120) perioperatively between the UBE and traditional groups. Furthermore, there were no significant differences in terms of incidence of transient numbness (OR=1.03, 95% CI 0.22~4.84, P=0.970), incidence of incomplete decompression (OR=0.97, 95% CI 0.18~5.33, P= 0.970) and incidence of revision surgery (OR=0.78, 95%CI 0.17~3.61, P=0.750), and incidence of cage subsidence (OR=0.86, 95%CI 0.30~ 2.47, P=0.780) between the two groups. [Conclusion] UBE lumbar interbody fusion is as safe as conventional lumbar interbody fusion sur- gery.